Home/Response Pharmaceuticals/William Sasiela, Ph.D.
WS

William Sasiela, Ph.D.

Chief Medical Officer

Response Pharmaceuticals

Response Pharmaceuticals Pipeline

DrugIndicationPhase
RDX-002Antipsychotic-Induced Weight Gain (AIWG)Phase 1b